cause of low HCo3 and pCo2 in necrotising fasciitis
necrotizing fasciitis metabolic acidosis lactic acid
H⁺ + Lactate⁻. The excess H⁺ is buffered by HCO3⁻:
H⁺ + HCO3⁻ → H2CO3 → H2O + CO2CO2 + H2O → H2CO3 → H⁺ + HCO3⁻ (shifts left, consuming H⁺ and raising pH back toward normal).Expected pCO2 = (1.5 × [HCO3⁻]) + 8 ± 2 - National Kidney Foundation Primer, 8e
| Finding | Mechanism | Primary Driver |
|---|---|---|
| Low HCO3 | Buffering of excess H⁺ from lactic acid; HCO3 consumed | Tissue ischaemia, anaerobic metabolism, septic shock |
| Low pCO2 | Compensatory hyperventilation to blow off CO2 | Chemoreceptor stimulation by low pH |
management can we have to give bicarbonate
sodium bicarbonate lactic acidosis sepsis treatment
"Bicarbonate administration does not address the underlying cause of the acidosis, and treatment should be directed at the underlying reason (e.g., treatment of sepsis, removal of toxins, dialysis for renal failure)."
- Current Surgical Therapy 14e
| Problem | Mechanism |
|---|---|
| Paradoxical intracellular acidosis | HCO3⁻ + H⁺ → H2CO3 → CO2 + H2O. The CO2 rapidly diffuses INTO cells and acidifies them, even as extracellular pH rises. Bicarbonate itself stays extracellular. |
| Worsens lactate production | Raising extracellular pH can actually stimulate phosphofructokinase (PFK), increasing anaerobic glycolysis and generating MORE lactate. |
| Hypernatraemia | Bicarbonate is given as a hypertonic solution (8.4% NaHCO3 = 1000 mmol/L sodium) - causes cellular dehydration. |
| Volume overload | Large volumes of sodium bicarbonate add a significant sodium/water load. |
| No survival benefit | A study of critically ill patients with pH <7.20 showed that raising pH to >7.3 with bicarbonate infusion did not improve survival. |
| Scenario | Bicarbonate? |
|---|---|
| pH 7.2-7.35 | No - treat the cause |
| pH 7.1-7.2 | Controversial - most avoid unless vasopressor-resistant shock |
| pH < 7.1 | Consider cautiously, as a bridge while surgical/medical treatment takes effect |
| pH < 7.1 + AKI stage 2-3 | Yes - evidence supports benefit in this subgroup |